Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Relationship of patent ductus arteriosus management with neonatal AKI

Abstract

Objective

Investigate relationship between management of patent ductus arteriosus (PDA) and acute kidney injury (AKI) in very low birthweight neonates.

Study Design

Retrospective cohort study of neonates, <1500 g, admitted to 24 NICUs, 1/1/14 – 3/31/14. AKI diagnosed using the neonatal modified KDIGO definition; diagnosis and treatment of PDA extracted from the medical record. Demographics, clinical characteristics, and AKI stage compared using chi-square and analysis of variance. A general estimating equation logistic regression used to estimate adjusted odds ratios.

Results

Of 526 neonates with sufficient data to diagnose AKI, 157 (30%) had PDA (61 conservative management, 62 pharmacologic treatment only, 34 surgical ligation). In analyses adjusted for sex, birthweight, gestational age, caffeine, nephrotoxin exposure, vasopressor and mechanical ventilation use, with conservative management as reference, there were no differences among treatment cohorts in the odds of AKI.

Conclusion

The underlying physiology of PDA, not management strategy, may determine the likelihood of AKI in neonates <1500 g.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CONSORT diagram of study population.

Similar content being viewed by others

References

  1. Elmas AT, Tabel Y, Ozdemir R. Risk factors and mortality rate in premature babies with acute kidney injury. J Clin Lab Anal. 2018;32:e22441.

    Article  Google Scholar 

  2. Jetton JG, Guillet R, Askenazi DJ, Dill L, Jacobs J, Kent AL, et al. Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates: design of a retrospective cohort study. Front Pediatr. 2016;4:68.

    Article  Google Scholar 

  3. Srinivasan N, Schwartz A, John E, Price R, Amin S. Acute kidney injury impairs postnatal renal adaptation and increases morbidity and mortality in very low-birth-weight infants. Am J Perinatol. 2018;35:39–47.

    Article  Google Scholar 

  4. Weintraub AS, Connors J, Carey A, Blanco V, Green RS. The spectrum of onset of acute kidney injury in preterm infants less than 30 weeks gestation. J Perinatol. 2016;36:47–480.

    Article  Google Scholar 

  5. Velazquez DM, Reidy KJ, Sharma M, Kim M, Vega M, Havranek T. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns. J Matern Fetal Neonatal Med. 2019;32:3209–14.

    Article  Google Scholar 

  6. Bomelburg T, Jorch G. Abnormal blood flow patterns in renal arteries of small preterm infants with patent ductus arteriosus detected by Doppler ultrasonography. Eur J Pediatr. 1989;148:660–4.

    Article  CAS  Google Scholar 

  7. Aygün A, Poryo M, Wagenpfeil G, Wissing A, Ebrahimi-Fakhari D, Zemlin M, et al. Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. Acta Paediatr. 2019;108:645–53.

    Article  Google Scholar 

  8. Majed B, Bateman DA, Uy N, Lin F. Patent ductus arteriosus is associated with acute kidney injury in the preterm infant. Pediatr Nephrol. 2019;34:1129–39.

    Article  Google Scholar 

  9. Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatr Res. 2008;64:291–7.

    Article  CAS  Google Scholar 

  10. Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicenter, multinational, observational cohort study. Lancet Child Adolesc Health. 2017;1:184–94.

    Article  Google Scholar 

  11. Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi DJ, et al. Neonatal acute kidney injury. Pediatrics. 2015;136:e463–e473.

    Article  Google Scholar 

  12. Radicioni M, Bini V, Campus GM, Camerini PG. Terlipressin-induced modifications of Doppler ultrasound signals of systemic arteries in preterm infants with vasoactive-resistant patent ductus arteriosus: a pilot study. J Clin Ultrasound. 2018;46:202–8.

    Article  CAS  Google Scholar 

  13. Bonsante F, Ramful D, Binquet C, Samperiz S, Daniel S, Gouyon JB, et al. Low renal oxygen saturation at near-infrared spectroscopy on the first day of life is associated with developing acute kidney injury in very preterm infants. Neonatology. 2019;115:198–204.

    Article  CAS  Google Scholar 

  14. Guignard JP. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol. 2002;26:398–405.

    Article  Google Scholar 

  15. Van-Bel F, Van-Zoeren D, Schipper J, Guit GL, Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr. 1990;116:965–70.

    Article  CAS  Google Scholar 

  16. Van-Bel F, Guit GL, Schipper J, van-de-Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr. 1991;118:621–6.

    Article  CAS  Google Scholar 

  17. Bensman A. Non-steroidal anti-inflammatory drugs (NSAIDs) systemic use: the risk of renal failure. Front Pediatr. 2020;7:517.

    Article  Google Scholar 

  18. Kent AL, Brown L, Broom M, Broomfield A, Dahlstrom JE. Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury. Pediatr Nephrol. 2012;27:1111–7.

    Article  Google Scholar 

  19. Sellmer A, Bech BH, Bjerre JV, Schmidt MR, Hjortdal VE, Esberg G, et al. Urinary neutrophil gelatinase-associated lipocalin in the evaluation of patent ductus arteriosus and AKI in very preterm neonates: a cohort study. BMC Pediatr. 2017;17:7.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank all the members of the Neonatal Kidney Collaborative who participated in the AWAKEN study: University of Alabama, Birmingham: David Askenazi, MD; N. Ambalavanan, MD; Russell Griffin, PhD; Cincinnati Children’s Hospital: Stuart Goldstein, MD; Amy Nathan, MD; James Greenberg, MD; Canberra Hospital: Alison Kent, MD (currently at the University of Rochester); Jeffrey Fletcher, MD; Farah Sethna, MD; Children’s Hospital of Colorado: Danielle Soranno, MD; Jason Gien, MD; Katja Gist, MD; Children’s Hospital at Montefiore/Albert Einstein: Mamta Fuloria, MD; Kim Reidy, MD; Frederick Kastel, MD; Natalie Uy, MD; Children’s National Medical Center: Mary Revenis, MD; Sofia Perrazo, MD; Shantanu Rastogi, MD; Golisano Children’s Hospital University of Rochester: George Schwartz, MD; Carl T. D’Angio, MD; Ronnie Guillet, MD, PhD; Erin Rademacher, MD; Ahmed El Samra, MD (currently Union Hospital, Terre Haute); Ayesa Mian, MD; Maimonides Medical Center: Juan Kupferman, MD; Alok Bhutada, MD; McGill University: Michael Zappitelli, MD; Pia Wintermark, MD; Medanta, Medicity The Cradle: Sanjay Wazir, MD; Sidharth Sethi, MD; Sandeep Dubey, MD; Metrohealth Medical Center: Maroun Mhanna, MD; Deepak Kumar, MD; Rupesh Raina, MD; Nationwide Children’s Hospital: Susan Ingraham, MD; Arwa Nada, MD; Elizabeth Bonachea, MD; Stonybrook University: Richard Fine, MD; Robert Woroniecki, MD; Shanthy Sridhar, MD; Texas Children’s Hospital: Ayse Ariken, MD; Christopher Rhee, MD; Tufts Medical Center: Lawrence Milner, MD; Alexandra Smith, MD; Julie Nicoletta, MD; University of British Columbia: Cherry Mammen, MD; Avash Jeet Singh, MD; Anne Synnes, MD; University of Iowa: Jennifer Jetton, MD; Tarah Colaizy, MD; Jonathan Klein, MD; Patrick Brophy (currently University of Rochester); University of Kentucky: Aftab Chishti, MD; Mina Hanna, MD; University of Miami: Carolyn Abitbol, MD; Marissa Defreitas, MD; Shahnaz Duara, MD; Salih Yasin, MD; University of Michigan: David Selewski, MD (currently Medical University of South Carolina); Subrata Sarker, MD; University of New Mexico: Craig Wong, MD; A. Staples, MD; Robin Ohls, MD; Catherine Joseph, MD (currently Texas Children’s Hospital); Tara Dupont, MD (currently University of Utah); University of Virginia: Jennifer Charlton, MD; Jonathan Swanson, MD; Matthew Harer (currently University of Wisconsin); Patricio Ray, MD; University of Washington: Sangeeta Hingorani, MD; Christine Hu, MD; Sandra Juul, MD.

The Neonatal Kidney Collaborative

David Askenazi5; N. Ambalavanan5; Russell Griffin5; Stuart Goldstein6; Amy Nathan6; James Greenberg6; Alison Kent7; Jeffrey Fletcher7; Farah Sethna7; Danielle Soranno8; Jason Gien8; Katja Gist8; Mamta Fuloria9; Kim Reidy9; Frederick Kastel9; Natalie Uy9; Mary Revenis10; Sofia Perrazo10; Shantanu Rastogi10; George Schwartz11; Carl T. D’Angio11; Ronnie Guillet11; Erin Rademacher11; Ahmed El Samra11,28; Ayesa Mian11; Juan Kupferman12; Alok Bhutada12; Michael Zappitelli13; Pia Wintermark13; Sanjay Wazir14; Sidharth Sethi14; Sandeep Dubey14; Maroun Mhanna15,29; Deepak Kumar15; Rupesh Raina15; Susan Ingraham16; Arwa Nada16; Elizabeth Bonachea16; Richard Fine17; Robert Woroniecki17; Shanthy Sridhar17; Ayse Ariken18; Christopher Rhee18; Lawrence Milner19; Alexandra Smith19; Julie Nicoletta19; Cherry Mammen20; Avash Jeet Singh20; Anne Synnes20; Jennifer Jetton21; Tarah Colaizy21; Jonathan Klein21; Patrick Brophy21,30; Aftab Chishti22; Mina Hanna22; Carolyn Abitbol23; Marissa Defreitas23; Shahnaz Duara23; Salih Yasin23; David Selewski24,31; Subrata Sarker24; Craig Wong25; A. Staples25; Robin Ohls25; Catherine Joseph25,32; Tara Dupont25,33; Jennifer Charlton26; Jonathan Swanson26; Matthew Harer26,34; Patricio Ray26; Sangeeta Hingorani27; Christine Hu27; Sandra Juul27.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

RGu designed the study, acquired data, drafted the manuscript and approved the final version. DS acquired data, contributed to the design of the study, edited the manuscript and approved the final version. RGr performed the statistical analyses, edited the manuscript and approved the final version. SR acquired data, edited the manuscript and approved the final version. DA contributed to the design of the study, edited the manuscript and approved the final version. CD contributed to the design of the study, edited the manuscript and approved the final version.

Corresponding author

Correspondence to Ronnie Guillet.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Members of the Neonatal Kidney Collaborative are listed below Acknowledgements.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guillet, R., Selewski, D.T., Griffin, R. et al. Relationship of patent ductus arteriosus management with neonatal AKI. J Perinatol 41, 1441–1447 (2021). https://doi.org/10.1038/s41372-021-01054-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-021-01054-1

This article is cited by

Search

Quick links